Insulet Corp (NASDAQ:PODD)

29.75
Delayed Data
As of Apr 17
 -0.24 / -0.80%
Today’s Change
27.02
Today|||52-Week Range
47.97
-35.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$1.7B

Company Description

Insulet Corp. engages in the development, manufacture and marketing of an insulin infusion system for people with insulin-dependent diabetes. Through its OmniPod Insulin Management System, the company seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod Insulin Management System is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and fully-automated cannula insertion. The company's current product offering consists of diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. Insulet was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Bedford, MA.

Contact Information

Insulet Corp.
600 Technology Park Drive
Billerica Massachusetts 01730
P:(978) 600-7000
Investor Relations:
(978) 600-7717

Employees

Shareholders

Mutual fund holders68.03%
Other institutional47.50%
Individual stakeholders26.36%

Top Executives

Patrick J. SullivanPresident, Chief Executive Officer & Director
William Patrick RyanChief Operating Officer
Allison DorvalChief Financial Officer
Paul LucidiChief Information Officer
Howard ZisserMedical Director

To view my watchlist

Not a member yet?

Sign up now for a free account